The board of directors at Qualigen Therapeutics is comprised of experienced professionals from a variety of industries. The President, Mike Haynes, has experience in accounting and finance from his time as the CFO at Ligand Pharmaceuticals and the CEO at NeuroCircuit Therapeutics. He also has an Executive Degree from the Stanford Graduate School of Business. The Vice President, Player & Employee Development at National Football League, also has a degree in finance from the W. P. Carey School of Business.
View all